Cover Image

Corrigendum to "Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress"

Saved in:

Bibliographic Details
Main Authors:	Anna Tarocco (Author), Elisa Ballardini (Author), Maria Raffaella Contiero (Author), Giampaolo Garani (Author), Silvia Fanaro (Author)
Format:	Book
Published:	Hindawi Limited, 2015-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
by: Anna Tarocco, et al.
Published: (2015)

Corrigendum: Single nucleotide polymorphisms interactions of the surfactant protein genes associated with respiratory distress syndrome susceptibility in preterm infants
by: Shaili Amatya, et al.
Published: (2022)

The Common Haplotype GATGACA in Surfactant-Protein B Gene Is Protective for Respiratory Distress Syndrome in Preterm Neonates
by: Silvia Mikolajcikova, et al.
Published: (2022)

Single Nucleotide Polymorphisms Interactions of the Surfactant Protein Genes Associated With Respiratory Distress Syndrome Susceptibility in Preterm Infants
by: Shaili Amatya, et al.
Published: (2021)

Surfactant therapy for acute respiratory distress in infants
by: Corrado Moretti, et al.
Published: (2014)

Genes polymorphism of surfactant protein B and respiratory morbidity in preschoolers
by: O. Mazulov, et al.
Published: (2017)

Genes polymorphism of surfactant protein B and respiratory morbidity in preschoolers
by: O. Mazulov, et al.
Published: (2017)

Treatment of acute respiratory distress syndrome in secondary surfactant deficiency in neonates
by: Heru Samudro, et al.
Published: (2016)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
by: Mandy Brasher, et al.
Published: (2021)

FiO2 Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome
by: Piotr Kruczek, et al.
Published: (2021)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
by: Frans J. Walther, et al.
Published: (2022)

Comparison of Respiratory Outcomes between Less Invasive Surfactant Administration and the Intubation-Surfactant-Extubation Technique in Premature Infants with Respiratory Distress Syndrome
by: Hye Seon Kim, et al.
Published: (2020)

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
by: J Wells Logan, et al.
Published: (2009)

Diagnostic utility of lung ultrasound in predicting the need for surfactant therapy in preterm neonates with respiratory distress
by: Pari Singh, et al.
Published: (2023)

Practical considerations when administering surfactants to preterm infants with respiratory distress syndrome
by: Heui Seung Jo
Published: (2019)

Surfactant Therapy for Respiratory Distress Syndrome in High- and Ultra-High-Altitude Settings
by: Xudong Duan, et al.
Published: (2022)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
by: Shengguang Wang, et al.
Published: (2021)

Surfactant preparations for preterm infants with respiratory distress syndrome: past, present, and future
by: Ga Won Jeon
Published: (2019)

Early Immunomodulatory Effects of Different Natural Surfactant Preparations in Preterms With Respiratory Distress
by: Mehmet Yalaz, et al.
Published: (2022)

Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant
by: van Zyl JM, et al.
Published: (2013)

Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome
by: Xing-An Wang, et al.
Published: (2020)

Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
by: Ji Won Koh, et al.
Published: (2018)

Early versus late extubation after surfactant replacement therapy for respiratory distress syndrome
by: Mohamed Garib, et al.
Published: (2015)

Comparison of the Efficacy of Three Natural Surfactants in Preterm Turkish Newborns with Respiratory Distress Syndrome
by: Fatma Hilal Yılmaz, et al.
Published: (2021)

Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates
by: Fatemeh Sabzevari, et al.
Published: (2023)

Minimally Invasive Surfactant Administration for the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter Randomized Study in China
by: Tongyan Han, et al.
Published: (2020)

CPAP failure in the management of preterm neonates with respiratory distress syndrome where surfactant is scarce. A prospective observational study
by: Yaser Abdallah, et al.
Published: (2023)

Clinical and genetic spectrum of interstitial lung disease in Chinese children associated with surfactant protein C mutations
by: Da Hong, et al.
Published: (2019)

Comparison of minimally invasive surfactant therapy with intubation surfactant administration and extubation for treating preterm infants with respiratory distress syndrome: a randomized clinical trial
by: Mohammad Kazem Sabzehei, et al.
Published: (2022)

Outcome of Very Premature Newborn Receiving an Early Second Dose of Surfactant for Persistent Respiratory Distress Syndrome
by: Eva Greiner, et al.
Published: (2021)

Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial
by: Yong Yang, et al.
Published: (2022)

Pulmonary insufficiency of extreme prematurity (PIEP) and surfactant deficiency disease (SDD) - It is time to classify respiratory distress syndrome (RDS) in preterm neonates
by: Deepti Thandaveshwara, et al.
Published: (2024)

A multicentre neonatal interventional randomised controlled trial of nebulized surfactant for preterm infants with respiratory distress: Neo-INSPIRe trial protocol
by: Ilse Lategan, et al.
Published: (2023)

A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study
by: Andrea Wolfler, et al.
Published: (2019)

EXOGENOUS SURFACTANTS OF NATURAL ORIGIN IN THE TREATMENT OF RESPIRATORY DISTRESS SYNDROME - COMPARATIVE COMPOSITION, BIOPHYSICAL PROPERTIES AND CLINICAL EFFECTIVENESS
by: D.О. Dobryanskyy
Published: (2020)

Surfactant Protein B Deficiency Caused by Homozygous C248X Mutation-A Case Report and Review of the Literature
by: Stefan Kurath-Koller, et al.
Published: (2015)

Respiratory symptoms among infants at risk for asthma: association with surfactant protein A haplotypes
by: Bracken Michael B, et al.
Published: (2007)

Allogeneic Mesenchymal Stromal Cells as a Global Pediatric Prospective Approach in the Treatment of Respiratory Failure Associated with Surfactant Protein C Dysfunction
by: Gloria Pelizzo, et al.
Published: (2023)

Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
by: Majid Mohammadizadeh, et al.
Published: (2015)

A modern understanding of the surfactant protein mutations role in the formation of interstitial lung diseases in newborns and infants
by: O.L. Logvinova, et al.
Published: (2018)